Drugs can take a decade of research and over a billion dollars' worth of development before they reach the market. Resources are wasted in the pre-discovery phase through a trial and error process that yields more error than success.
There are hidden insights in biomedical data, waiting to be discovered and to lead towards promising drug candidates.
Unfortunately, these patterns are too complex and diffuse to be detected by the human mind; this is where a more powerful solution comes in – Standigm’s latest artificial intelligence technologies.
Standigm removes the traditional guesswork from data analysis by using our innovative AI, automatically examining whole biomedical databases to learn what is hiding just out of sight.
By applying our state-of-the-art machine learning technology to real data, we eliminate some of the uncertainty in the drug discovery process; instead of fishing in the dark for effective treatments, we can focus on developing candidates that are primed for success.
Standigm cuts through the noise and presents data that are most pertinent to the treatment of diseases, saving time and money by shortening the development cycle.
